BCYC vs ECL · rev $35.3M vs P/E 35, rev $4.01B
Bicycle Therapeutics Ltd (BCYC) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BCYC revenue for 2024-12-31 was $35.3M. Net income was -$169.0M. Revenue was up 30.8% from 2023-12-31 to 2024-12-31. BCYC currently screens at market cap $554.0M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BCYC currently screens at market cap $554.0M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BCYC and ECL stock pages for the full models.
Not investment advice.